HOME >> BIOLOGY >> NEWS
American Physical Society March Meeting 2003

the possibility of testing the theory of superstrings and the search for extra dimensions. (Session F1)

LEFT-HANDED MATERIALS
Steps toward a "perfect lens" and lenses that bend microwave beams the opposite way to normal lenses have been taken by an MIT/Harvard collaboration (K22.1, K22.2). There is debate over whether or not these theoretically possible devices could actually be created, but the new experimental results put part of that debate to rest. Passing the microwaves through a slab of "left-handed material" (LHM), as these devices are known, results in a focused spot of microwave power, something that would not happen with normal right-handed materials. Other researchers from the University of Utah (K22.4) suggest that LHMs can be used for a new 3D imaging process.

MISCONDUCT IN PHYSICS
Recent evidence of professional misconduct in two different areas of physics has caused the community to think deeply about such issues. In November 2002, the APS Council approved new statements of professional ethics and revised its "Guidelines for Professional Conduct". A panel session, including members of the Lucent and Berkeley review committees will discuss these issues allowing time for input from the community. The session will be chaired by APS President Myriam Sarachik (CCNY-CUNY). Panelists include Malcolm Beasley (Stanford), Pierre Hohenberg (Yale), Arthur Bienenstock (Stanford), George Trilling (Lawrence Berkeley National Laboratory). (Session U1)

CARBON NANOTUBES - A TOOL FOR ALL OCCASIONS
Carbon nanotubes are now a huge focus of research and development with applications arising in diverse areas. They are being studied as ultrasensitive sensors of gas molecules in the environment, as opticalsensors, and as mechanical sensors that can detect very slight bending. Nanotubes are also being explored as the basis for electronic devices. Results will be presented for nanotube version of transistors, the
'"/>

Contact: David Harris
harris@aps.org
301-209-3238
American Physical Society
23-Jan-2003


Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology news :

1. Highlights of the October 2004 Journal of the American Dietetic Association
2. The American Phytopathological Society announces 2004 awards
3. Tips from the Journals of the American Society for Microbiology
4. Highlights of American Chemical Society national meeting in Philadelphia, Aug. 22-26
5. NIH roadmap for biomedical research focus of chemists at American Chemical Society meeting
6. Tips from the journals of the American Society for Microbiology
7. Genetic mutation linked to more aggressive breast cancer found more often in African-Americans
8. More aggressive breast cancer tumors found in African American women
9. American Society of Mammalogists honors CI president Russell Mittermeier with Aldo Leopold award
10. Tips from the Journals of the American Society for Microbiology
11. Most Americans not sure about the sources of high cholesterol

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: American Physical Society March Meeting

(Date:10/16/2014)... Cancer constantly wages war on the human body. ... a stalemate. In pancreatic cancer, this stalemate—known as ... becoming aggressively malignant, a phenomena that is poorly ... in the laboratory of Salvatore Torquato, a Professor ... the conditions surrounding tumor dormancy and the switch ...
(Date:10/16/2014)... cultivated efficiently, they are anything but sustainable: environmental ... cultivation is becoming increasingly evident. Despite their disadvantages, ... are regarded as the sole possibility of achieving ... finds Bernhard Schmid, an ecology professor at the ... of agriculture and forestry. After all, a new ...
(Date:10/15/2014)... , Oct. 15, 2014 Sandata Technologies, ... home and community-based care, today announced it released ... Sandata,s Santrax® Electronic Visit Verification™ Solution (EVV™)  for ... a home health company founded in 1996 and ... . The study details the ...
Breaking Biology News(10 mins):Modeling tumor dormancy 2Plant communities produce greater yield than monocultures 2Plant communities produce greater yield than monocultures 3Sandata Announces Case Study with Quality Care Services, Inc. 2
(Date:10/22/2014)... , Oct. 22, 2014 Nuvilex, Inc. ... approximately 400 million people worldwide are living with diabetes, ... people by 2030.  The global market for diabetes treatments ... approximately 330,000 people worldwide died from pancreatic cancer.  Pancreatic ... due to cancer in the United States ...
(Date:10/20/2014)... The report “Pharmacy Automation Systems Market ... Labeling Systems, Table-top Counters) by End-user (Inpatient Pharmacy ... Trends to 2019” analyzes and studies the major ... Europe, Asia-Pacific, and the Rest of the World ... figures spread through 300 pages and in-depth TOC ...
(Date:10/20/2014)... PARK, Calif. , Oct. 20, 2014 /PRNewswire/ ... today that the Company has signed a Notice ... of Regenerative Medicine (CIRM), effective October 1, 2014.  ... Clinical Development payments and the release of additional ... million CIRM grant award for clinical development of ...
(Date:10/20/2014)... Md. , Oct. 20, 2014  GenVec, Inc. (NASDAQ: ... Zola P. Horovitz , Ph.D., from its board of directors ... board in August 2003, and served as its chairman from ... served on the Nominating and Corporate Governance and Audit Committees ... for more than a decade of dedicated service to GenVec, ...
Breaking Biology Technology:Nuvilex Brief Analyst Report: Thinking Outside the Box by BrokerBank Securities, Inc. 2Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 2Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 3Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 4Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 4Zola P. Horovitz To Retire From GenVec Board 2
Cached News: